面对手术无法治愈的疾病时，是否应进行根治性肾切除术？

Should radical nephrectomy be performed in the face of surgically incurable disease?

作者信息

Yonover P M, Flanigan R C

机构信息

Loyola University Medical Center, Department of Urology, Maywood, Illinois, USA.

出版信息

Curr Opin Urol. 2000 Sep;10(5):429-34. doi: 10.1097/00042307-200009000-00011.

DOI:10.1097/00042307-200009000-00011

PMID:11005447

Abstract

The role of cytoreductive nephrectomy in the management of metastatic renal cancer remains controversial. Recent trials, like SWOG 8949 have suggested the usefulness of this approach at least in selected patients with good performance status and other favorable indicators. The timing of cytoreductive nephrectomy has also been controversial and remains so to this time.

摘要

减瘤性肾切除术在转移性肾癌治疗中的作用仍存在争议。近期的试验，如SWOG 8949研究表明，这种方法至少对部分身体状况良好且有其他有利指标的患者是有用的。减瘤性肾切除术的时机也一直存在争议，至今仍是如此。